Critical Care Diagnostics: Global Market Forecasts to 2023 – Microbial and Infectious Diseases Test Segment is Anticipated to Grow at the Highest CAGR – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Critical
Care Diagnostics – Global Market Outlook (2017-2023)”
report
has been added to ResearchAndMarkets.com’s offering.

The Global Critical Care Diagnostics market accounted for $0.86 billion
in 2016 and is expected to reach $1.34 billion by 2023 growing at a CAGR
of 6.5% from 2016 to 2023.

Growing aging population and chronic health concerns, improving
advancements in technologies and rapid attentiveness, increasing
acceptance of these tests by physicians and patients are some of factors
triggering the market growth. Furthermore, growing incidence of chronic
disease such as cancer, heart disease, and diabetes are fuelling the
market growth.

However, increased price of the molecular diagnostics and shortage of
skilled professionals are some of the factors restraining the market
growth.

Microbial and Infectious diseases test segment is anticipated to grow at
the highest CAGR during the forecast period. The growth is owing to the
quick and accurate test results to diagnose the disease. Immunoproteins
diagnostic test segment accounted for largest market revenue due to
increase massive demand for early disease diagnosis.

North America represents as the largest market in terms of revenue. High
research and development activities, higher demand from U.S. boosting
the North America market. Asia Pacific is projected to dominate the
global market in terms of revenue due to rising specialty hospitals and
convalescing healthcare services and infrastructures in rural areas.

Segments Covered

Product Types

  • Cancer markers testing kit
  • Cardiometabolic monitoring kits
  • Fecal Occult testing kits
  • Drugs-Of-Abuse testing kits
  • Coagulation monitoring kits
  • Cholesterol test strips
  • Glucose monitoring kits
  • Pregnancy and fertility testing kits
  • Infectious Disease testing kits
  • Hematology testing kits
  • Other critical care diagnostics testing kits

Test Types

  • Hematology
  • Coagulation
  • Routine & Special Chemistry
  • Microbial & Infectious Test
  • Flow Cytometry
  • Immunoproteins
  • Other Test Types

Prescription Modes

  • OTC Testing Kits
  • Prescription-Based Testing Kits

End Users

  • Ambulatory surgical centers
  • Home
  • Hospitals
  • Research Laboratories

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Critical Care Diagnostics Market, By Product Type

6 Global Critical Care Diagnostics Market, By Test Type

7 Global Critical Care Diagnostics Market, By Prescription Mode

8 Global Critical Care Diagnostics Market, By End User

9 Global Critical Care Diagnostics Market, By Geography

10 Key Developments

11 Company Profiling

  • Abbott Laboratories
  • Alere, Inc.
  • Bayer Healthcare AG
  • Beckman Coulter
  • Becton Dickinson & Co.
  • BioMerieux, Inc.
  • Bio-Rad Laboratories
  • Biosensors Japan
  • Chembio Diagnostic Systems, Inc.
  • EKF Diagnostics
  • Nanomix Inc.
  • Nova Biomedical
  • Roche Diagnostics Ltd.
  • Siemens Healthcare Diagnostics
  • Sysmex Corporation

For more information about this report visit https://www.researchandmarkets.com/research/sclgs4/critical_care?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Diagnostics,
Intensive
Care and Emergency Medicine